Christopher Hebbes

Pharmacological Characterization of the Nociceptin/Orphanin FQ Receptor Antagonist SB-612111 [(–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5 H-benzocyclohepten-5-ol]: In Vitro Studies

Barbara Spagnolo, Giacomo Carrà, Martina Fantin et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 97 citations · Full text

Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist

Claudio Trapella, Remo Guerrini, Laura Piccagli et al. · Bioorganic & Medicinal Chemistry · 2005 · 35 citations

Pain Medicine, Pharmacology, Immunology +10

Predictors of Severity and Survival in Acute Pancreatitis

Giuseppe Garcea, M. Gouda, Christopher Hebbes et al. · Pancreas · 2008 · 35 citations · Full text

[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a Highly Potent and Selective Agonist of the Nociceptin/Orphanin FQ Receptor

Giacomo Carrà, Anna Rizzi, Remo Guerrini et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 34 citations · Full text

Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies

Raffaella Vergura, E. Valenti, Christopher Hebbes et al. · Peptides · 2006 · 18 citations · Full text

Molecular Pharmacology, Vivo Studies, Functional Selectivity +9